Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,173 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
An extract of phase II and III trials on recent developments in managing neuropathic pain syndromes: diabetic peripheral neuropathy, trigeminal neuralgia, and postherpetic neuralgia.
Upshaw WC, Soileau LG, Storey NR, Perkinson KA, Luther PM, Spillers NJ, Robinson CL, Miller BC, Ahmadzadeh S, Viswanath O, Shekoohi S, Kaye AD. Upshaw WC, et al. Among authors: kaye ad. Expert Opin Emerg Drugs. 2024 Feb 29:1-10. doi: 10.1080/14728214.2024.2323193. Online ahead of print. Expert Opin Emerg Drugs. 2024. PMID: 38410863 Review.
Testosterone replacement therapy: clinical considerations.
Luther PM, Spillers NJ, Talbot NC, Sinnathamby ES, Ellison D, Kelkar RA, Ahmadzadeh S, Shekoohi S, Kaye AD. Luther PM, et al. Among authors: kaye ad. Expert Opin Pharmacother. 2024 Jan-Apr;25(1):25-35. doi: 10.1080/14656566.2024.2306832. Epub 2024 Feb 1. Expert Opin Pharmacother. 2024. PMID: 38229462 Review.
Anesthesia Liability Related to Pre-existing Conditions.
Kaye AD, Barrie S, Kelkar RA, Shekoohi S. Kaye AD, et al. Anesthesiol Clin. 2024 Mar;42(1):33-40. doi: 10.1016/j.anclin.2023.08.003. Epub 2023 Sep 15. Anesthesiol Clin. 2024. PMID: 38278590 Review.
AMONDYS 45 (Casimersen), a Novel Antisense Phosphorodiamidate Morpholino Oligomer: Clinical Considerations for Treatment in Duchenne Muscular Dystrophy.
Vasterling ME, Maitski RJ, Davis BA, Barnes JE, Kelkar RA, Klapper RJ, Patel H, Ahmadzadeh S, Shekoohi S, Kaye AD, Varrassi G. Vasterling ME, et al. Among authors: kaye ad. Cureus. 2023 Dec 28;15(12):e51237. doi: 10.7759/cureus.51237. eCollection 2023 Dec. Cureus. 2023. PMID: 38283433 Free PMC article. Review.
Guselkumab, a Novel Monoclonal Antibody Inhibitor of the p19 Subunit of IL-23, for Psoriatic Arthritis and Plaque Psoriasis: A Review of Its Mechanism, Use, and Clinical Effectiveness.
Kerut CK, Wagner MJ, Daniel CP, Fisher C, Henderson EJ, Burroughs CR, Amarasinghe S, Willett O, Ahmadzadeh S, Varrassi G, Shekoohi S, Kaye AD. Kerut CK, et al. Among authors: kaye ad. Cureus. 2023 Dec 31;15(12):e51405. doi: 10.7759/cureus.51405. eCollection 2023 Dec. Cureus. 2023. PMID: 38292958 Free PMC article. Review.
1,173 results